BETHESDA, Md., Oct. 23, 2009 (GLOBE NEWSWIRE) -- Micromet, Inc. (Nasdaq:MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, November 5, 2009, at 9:00 am Eastern Time (3:00 pm Central European Time) to discuss its financial results for the third quarter of 2009. Micromet anticipates releasing its financial results at 7:00 am Eastern Time (1:00 pm Central European Time) on Thursday, November 5, 2009.
